CD109 negatively regulates TGF-β1 signaling and enhances EGF signaling in glioblastoma cells, and might represent a critical link in the balance of signaling between these two oncogenic pathways that control inflammatory responses, cell migration and invasion (85). Here, TGFB1 is linked to glioblastoma.